Literature DB >> 18500570

Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note.

M C de Vries1, R J Rodenburg, E Morava, M Lammens, L P W van den Heuvel, G Christoph Korenke, J A M Smeitink.   

Abstract

We report a 5-year-old child carrying polymerase gamma (POLG1) mutations, but strikingly normal oxidative phosphorylation analysis in muscle, fibroblasts and liver. Mutations in POLG1 have so far been described in children with severe combined oxidative phosphorylation (OXPHOS) deficiencies and with the classical Alpers-Huttenlocher syndrome. The patient presented with a delayed psychomotor development and ataxia during the first two years of life. From the third year of life he developed epilepsy and regression in development, together with symptoms of visual impairment and sensorineuronal deafness. Cerebrospinal fluid showed elevated lactic acid and protein concentrations. An elder brother had died due to combined OXPHOS deficiencies. Despite the clinical similarity with the elder brother, except for liver involvement, the OXPHOS system analysis in a frozen muscle biopsy was normal. For this reason a fresh muscle biopsy was performed, which has the advantage of the possibility of measuring the substrate oxidation rates and ATP production, part of the mitochondrial energy-generating system (MEGS). During the same session, biopsies of liver and fibroblasts were taken. These three tissues showed normal measurements of the MEGS capacity. Based on the phenotype of Alpers-Huttenlocher syndrome in the elder brother, we decided to screen the POLG1 gene. Mutation analysis showed compound heterozygosity with two known mutations, A467T and G848S. The normal MEGS capacity in this patient expands the already existing complexity and heterogeneity of the childhood POLG1 patients and, on the basis of the high frequency of POLG1 mutations in childhood, warrants a liberal strategy with respect to mutation analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500570     DOI: 10.1007/s10545-008-0871-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

Authors:  Rita Horvath; Gavin Hudson; Gianfrancesco Ferrari; Nancy Fütterer; Sofia Ahola; Eleonora Lamantea; Holger Prokisch; Hanns Lochmüller; Robert McFarland; V Ramesh; Thomas Klopstock; Peter Freisinger; Fabrizio Salvi; Johannes A Mayr; Rene Santer; Marketa Tesarova; Jiri Zeman; Bjarne Udd; Robert W Taylor; Douglass Turnbull; Michael Hanna; Doreen Fialho; Anu Suomalainen; Massimo Zeviani; Patrick F Chinnery
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

2.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

Review 3.  DNA polymerase gamma in mitochondrial DNA replication and repair.

Authors:  Maria A Graziewicz; Matthew J Longley; William C Copeland
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

4.  POLG mutations in Alpers syndrome.

Authors:  K V Nguyen; E Østergaard; S Holst Ravn; T Balslev; E Rubaek Danielsen; A Vardag; P J McKiernan; G Gray; R K Naviaux
Journal:  Neurology       Date:  2005-09-21       Impact factor: 9.910

5.  POLG mutations and Alpers syndrome.

Authors:  Guido Davidzon; Michelangelo Mancuso; Silvio Ferraris; Catarina Quinzii; Michio Hirano; Heidi L Peters; Denise Kirby; David R Thorburn; Salvatore DiMauro
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

6.  Human NADH:ubiquinone oxidoreductase.

Authors:  J Smeitink; R Sengers; F Trijbels; L van den Heuvel
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

7.  Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.

Authors:  Emiliano González-Vioque; Alberto Blázquez; Daniel Fernández-Moreira; Belén Bornstein; Juan Bautista; Javier Arpa; Carmen Navarro; Yolanda Campos; Miguel A Fernández-Moreno; Rafael Garesse; Joaquin Arenas; Miguel A Martín
Journal:  Arch Neurol       Date:  2006-01

8.  Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood.

Authors:  Emmanuelle Sarzi; Alice Bourdon; Dominique Chrétien; Mohamed Zarhrate; Johanna Corcos; Abdelhamid Slama; Valérie Cormier-Daire; Pascale de Lonlay; Arnold Munnich; Agnès Rötig
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

9.  Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology.

Authors:  Antoon J M Janssen; Frans J M Trijbels; Rob C A Sengers; Liesbeth T M Wintjes; Wim Ruitenbeek; Jan A M Smeitink; Eva Morava; Baziel G M van Engelen; Lambert P van den Heuvel; Richard J T Rodenburg
Journal:  Clin Chem       Date:  2006-03-16       Impact factor: 8.327

10.  Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.

Authors:  Maaike C de Vries; Richard J Rodenburg; Eva Morava; Edwin P M van Kaauwen; Henk ter Laak; Reinier A Mullaart; Irina N Snoeck; Peter M van Hasselt; Peter Harding; Lambert P W van den Heuvel; Jan A M Smeitink
Journal:  Eur J Pediatr       Date:  2006-09-07       Impact factor: 3.860

View more
  4 in total

Review 1.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

2.  POLG-Associated Ataxia Presenting as a Fragile X Tremor/Ataxia Phenocopy Syndrome.

Authors:  Martin Paucar; Martin Engvall; Lisa Gordon; Emma Tham; Matthis Synofzik; Per Svenningsson
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

3.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.

Authors:  Ewa Pronicka; Anna Weglewska-Jurkiewicz; Maciej Pronicki; Jolanta Sykut-Cegielska; Pawel Kowalski; Magdalena Pajdowska; Irena Jankowska; Katarzyna Kotulska; Piotr Kalicinski; Joanna Jakobkiewicz-Banecka; Grzegorz Wegrzyn
Journal:  Med Sci Monit       Date:  2011-04

Review 4.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.